Business Context and Reporting Period
This Form 6-K, dated November 26, 2014, reports on the definitive interim results of the share-for-share exchange offer between UBS Group AG and UBS AG. The filing announces the successful conclusion of the extended initial acceptance period and the commencement of an additional acceptance period.
Key Financial Metrics and Transaction Data
The filing focuses on the mechanics of the corporate restructuring rather than standard operating financial metrics such as revenue or profit. Key transaction data includes:
- Total Issued UBS AG Shares: 3,844,560,913
- Total Shares Tendered: 3,475,356,441
- Overall Acceptance Ratio: 90.40% of all issued shares
- Shares Tendered by UBS Shareholders: 3,384,540,847 (90.18% acceptance ratio)
- Treasury Shares Tendered by UBS: 90,815,594
- Non-Tendered Shares: 369,204,472
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity for the reporting period.
Material Changes and Transaction Status
UBS Group AG has declared the share-for-share exchange offer unconditional as all offer conditions were satisfied or waived. Because the acceptance ratio exceeds 90% of the outstanding shares, UBS Group AG will own sufficient shares to ensure the squeeze-out of remaining UBS AG shares, though this process may take an extended period. An additional acceptance period of 11 Swiss trading days was initiated, running from November 26 to December 10, 2014.
Guidance, Outlook, and Risks
Outlook and Commentary: Management expects the squeeze-out process to proceed following the additional acceptance period. During the additional period, tendered shares will be assigned new security numbers and traded on a separate line on the SIX Swiss Exchange, allowing shareholders to sell tendered shares.
Risks and Contingencies: The filing includes extensive forward-looking statement disclaimers citing risks related to:
- Execution of strategic plans, including efficiency initiatives and Basel III risk-weighted asset reductions.
- Market developments, including liquidity, credit spreads, and interest rates.
- Regulatory changes in Switzerland, the US, and the UK regarding capital, liquidity, and structural reform.
- Uncertainty regarding FINMA approval of capital requirement reductions.
- Legal entity restructuring and the creation of new holding companies.
- Litigation, regulatory investigations, and operational failures.
Investor Verification Checklist
- Verify the final acceptance ratio after the additional acceptance period concludes on December 10, 2014.
- Confirm the timeline and regulatory approval for the squeeze-out of remaining minority shareholders.
- Review the separate EU AAP Prospectus for details on the public offering of UBS Group shares in the EEA.
- Check for updates on FINMA's approval of the supplemental operational risk-capital analysis and capital requirement reductions.
- Monitor the separate trading line (ISIN: CH0247704312) for tendered shares during the additional acceptance period.